Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer

A proposal for standardization of patient characteristic reporting and stratification

H. Sorbye, C. H. Köhne, D. J. Sargent, B. Glimelius

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background: Prognostic factors have the potential to determine the survival of patients to a greater extent than current antineoplastic agents. Despite this knowledge, there is no consensus on, first, what patient characteristics to report and, second, what stratification factors to use in metastatic colorectal cancer trials. Patients and methods: Seven leading oncology and medical journals were reviewed for phase II and III publications reporting on medical treatment of metastatic colorectal cancer patients during 2001-2005. One hundred and forty-three studies with 21 214 patients were identified. The reporting of patient characteristics and use of stratification was noted. Results: Age, gender, performance status, metastases location, sites and adjuvant chemotherapy were often reported (99-63%). Laboratory values as alkaline phosphatase, lactate dehydrogenase and white blood cell count, repeatedly found to be of prognostic relevance, were rarely reported (5-9%). Stratification was used in all phase III trials; however, only study centre was used with any consistency. Conclusion: There is considerable inconsistency in the reporting of patient characteristics and use of stratification factors in metastatic colorectal cancer trials. We propose a standardization of patient characteristics reporting and stratification factors. A common set of characteristics and strata will aid in trial reporting, interpretation and future meta-analyses.

Original languageEnglish (US)
Pages (from-to)1666-1672
Number of pages7
JournalAnnals of Oncology
Volume18
Issue number10
DOIs
StatePublished - Oct 2007

Fingerprint

Colorectal Neoplasms
Therapeutics
Medical Oncology
Adjuvant Chemotherapy
Leukocyte Count
L-Lactate Dehydrogenase
Antineoplastic Agents
Alkaline Phosphatase
Publications
Meta-Analysis
Neoplasm Metastasis
Survival

Keywords

  • Colorectal neoplasm
  • Metastatic disease
  • Patient characteristics
  • Prognosis
  • Stratification

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer : A proposal for standardization of patient characteristic reporting and stratification. / Sorbye, H.; Köhne, C. H.; Sargent, D. J.; Glimelius, B.

In: Annals of Oncology, Vol. 18, No. 10, 10.2007, p. 1666-1672.

Research output: Contribution to journalArticle

@article{c8927919ab884954afdfb098cd4aee2d,
title = "Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification",
abstract = "Background: Prognostic factors have the potential to determine the survival of patients to a greater extent than current antineoplastic agents. Despite this knowledge, there is no consensus on, first, what patient characteristics to report and, second, what stratification factors to use in metastatic colorectal cancer trials. Patients and methods: Seven leading oncology and medical journals were reviewed for phase II and III publications reporting on medical treatment of metastatic colorectal cancer patients during 2001-2005. One hundred and forty-three studies with 21 214 patients were identified. The reporting of patient characteristics and use of stratification was noted. Results: Age, gender, performance status, metastases location, sites and adjuvant chemotherapy were often reported (99-63{\%}). Laboratory values as alkaline phosphatase, lactate dehydrogenase and white blood cell count, repeatedly found to be of prognostic relevance, were rarely reported (5-9{\%}). Stratification was used in all phase III trials; however, only study centre was used with any consistency. Conclusion: There is considerable inconsistency in the reporting of patient characteristics and use of stratification factors in metastatic colorectal cancer trials. We propose a standardization of patient characteristics reporting and stratification factors. A common set of characteristics and strata will aid in trial reporting, interpretation and future meta-analyses.",
keywords = "Colorectal neoplasm, Metastatic disease, Patient characteristics, Prognosis, Stratification",
author = "H. Sorbye and K{\"o}hne, {C. H.} and Sargent, {D. J.} and B. Glimelius",
year = "2007",
month = "10",
doi = "10.1093/annonc/mdm267",
language = "English (US)",
volume = "18",
pages = "1666--1672",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer

T2 - A proposal for standardization of patient characteristic reporting and stratification

AU - Sorbye, H.

AU - Köhne, C. H.

AU - Sargent, D. J.

AU - Glimelius, B.

PY - 2007/10

Y1 - 2007/10

N2 - Background: Prognostic factors have the potential to determine the survival of patients to a greater extent than current antineoplastic agents. Despite this knowledge, there is no consensus on, first, what patient characteristics to report and, second, what stratification factors to use in metastatic colorectal cancer trials. Patients and methods: Seven leading oncology and medical journals were reviewed for phase II and III publications reporting on medical treatment of metastatic colorectal cancer patients during 2001-2005. One hundred and forty-three studies with 21 214 patients were identified. The reporting of patient characteristics and use of stratification was noted. Results: Age, gender, performance status, metastases location, sites and adjuvant chemotherapy were often reported (99-63%). Laboratory values as alkaline phosphatase, lactate dehydrogenase and white blood cell count, repeatedly found to be of prognostic relevance, were rarely reported (5-9%). Stratification was used in all phase III trials; however, only study centre was used with any consistency. Conclusion: There is considerable inconsistency in the reporting of patient characteristics and use of stratification factors in metastatic colorectal cancer trials. We propose a standardization of patient characteristics reporting and stratification factors. A common set of characteristics and strata will aid in trial reporting, interpretation and future meta-analyses.

AB - Background: Prognostic factors have the potential to determine the survival of patients to a greater extent than current antineoplastic agents. Despite this knowledge, there is no consensus on, first, what patient characteristics to report and, second, what stratification factors to use in metastatic colorectal cancer trials. Patients and methods: Seven leading oncology and medical journals were reviewed for phase II and III publications reporting on medical treatment of metastatic colorectal cancer patients during 2001-2005. One hundred and forty-three studies with 21 214 patients were identified. The reporting of patient characteristics and use of stratification was noted. Results: Age, gender, performance status, metastases location, sites and adjuvant chemotherapy were often reported (99-63%). Laboratory values as alkaline phosphatase, lactate dehydrogenase and white blood cell count, repeatedly found to be of prognostic relevance, were rarely reported (5-9%). Stratification was used in all phase III trials; however, only study centre was used with any consistency. Conclusion: There is considerable inconsistency in the reporting of patient characteristics and use of stratification factors in metastatic colorectal cancer trials. We propose a standardization of patient characteristics reporting and stratification factors. A common set of characteristics and strata will aid in trial reporting, interpretation and future meta-analyses.

KW - Colorectal neoplasm

KW - Metastatic disease

KW - Patient characteristics

KW - Prognosis

KW - Stratification

UR - http://www.scopus.com/inward/record.url?scp=34848887988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848887988&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm267

DO - 10.1093/annonc/mdm267

M3 - Article

VL - 18

SP - 1666

EP - 1672

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -